Re: Sorafenib in advanced clear-cell renal cell carcinoma

被引：1
|
作者：
Karakiewicz, Pierre I. [1 ]
Hutterer, Georg [1 ]
机构：
[1] Univ Montreal, Ctr Hlth, Dept Urol, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
来源：
EUROPEAN UROLOGY | 2007年 / 52卷 / 01期
关键词：
D O I：
10.1016/j.eururo.2007.04.014
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：279 / 280
页数：2
相关论文
共 50 条
  • [21] Obesity, Cholesterol, and Clear-Cell Renal Cell Carcinoma (RCC)
    Drabkin, Harry A.
    Gemmill, Robert M.
    ADVANCES IN CANCER RESEARCH, VOL 107, 2010, 107 : 39 - 56
  • [22] Integrated molecular analysis of clear-cell renal cell carcinoma
    Sato, Yusuke
    Yoshizato, Tetsuichi
    Shiraishi, Yuichi
    Maekawa, Shigekatsu
    Okuno, Yusuke
    Kamura, Takumi
    Shimamura, Teppei
    Sato-Otsubo, Aiko
    Nagae, Genta
    Suzuki, Hiromichi
    Nagata, Yasunobu
    Yoshida, Kenichi
    Kon, Ayana
    Suzuki, Yutaka
    Chiba, Kenichi
    Tanaka, Hiroko
    Niida, Atsushi
    Fujimoto, Akihiro
    Tsunoda, Tatsuhiko
    Morikawa, Teppei
    Maeda, Daichi
    Kume, Haruki
    Sugano, Sumio
    Fukayama, Masashi
    Aburatani, Hiroyuki
    Sanada, Masashi
    Miyano, Satoru
    Homma, Yukio
    Ogawa, Seishi
    NATURE GENETICS, 2013, 45 (08) : 860 - U191
  • [23] Dystroglycan expression in clear-cell type renal cell carcinoma
    Camerini, A.
    De Luca, F.
    Genovese, G.
    De Paola, B.
    Valsuani, C.
    Tartarelli, G.
    Donati, S.
    Rettino, A.
    Cittadini, A.
    Sgambato, A.
    Gentili, C.
    Amoroso, D.
    ANNALS OF ONCOLOGY, 2006, 17 : XI34 - XI35
  • [24] Efficacy and safety of sorafenib in patients with advanced clear-cell renal cell carcinoma (RCC) with diabetes: Results from the phase III TARGET study
    Oudard, S.
    Eisen, T.
    Szczylik, C.
    Siebels, M.
    Negrier, S.
    Chevreau, C.
    Cihon, F.
    Bukowski, R. M.
    Escudier, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] Re: Molecular Subtypes of Clear-cell Renal Cell Carcinoma Are Prognostic for Outcome After Complete Metastasectomy
    Dong, Baijun
    Xue, Wei
    EUROPEAN UROLOGY, 2018, 74 (06) : 841 - 841
  • [26] BILATERAL SYNCHRONOUS MULTIFOCAL RENAL CLEAR-CELL CARCINOMA
    Pothen, L.
    Rouviere, H.
    Sleiman, Bou W.
    Aydin, S.
    Feyaerts, A.
    Nica, M-, I
    Lambert, M.
    ACTA CLINICA BELGICA, 2013, 68 (01) : 75 - 76
  • [27] THYROID METASTASIS OF CLEAR-CELL RENAL-CARCINOMA
    LEHUR, PA
    COTE, RA
    POISSON, J
    BOCTOR, M
    ELHILALI, M
    KANDALAFT, N
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1983, 128 (02) : 154 - 156
  • [28] Targeting HIF2α in Clear-Cell Renal Cell Carcinoma
    Ricketts, Christopher J.
    Crooks, Daniel R.
    Linehan, W. Marston
    CANCER CELL, 2016, 30 (04) : 515 - 517
  • [29] Molecular profile of sunitinib resistance in clear-cell renal cell carcinoma
    Torras, Oscar Reig
    Marin-Aguilera, Mercedes
    Jimenez, Natalia
    Laia, Pare
    Galvan, Patricia
    Mallofre, Carme
    Prat, Aleix
    Mellado, Begona
    CANCER RESEARCH, 2017, 77
  • [30] Novel treatment strategies in clear-cell metastatic renal cell carcinoma
    van Spronsen, DJ
    de Weijer, KJM
    Mulders, PFA
    De Mulder, RHM
    ANTI-CANCER DRUGS, 2005, 16 (07) : 709 - 717
12345